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Introduction
Since the occurrence of plasma volume depletion represents a typical pathophysiological feature in preeclampsia [5, 7, 10] , several groups have demonstrated favorable results in the treatment with plasma volume expanders [4, 6, 8, 9, 18, 19, 20, 22] . During hypervolemic hemodilution with low molecular dextran, both SCHWARZ and RETZKE [19] and CLOEREN et al. [4] described increased impulse rates using isotope techniques as an index of elevated placental perfusion. In contrast, JOUPPILA et al. [12] estimated no improvement of placental perfusion in the course of a 100 ml infusion of 20% human albumin. For the early detection of heart decompensation attributed to fluid overload during plasma expander therapy intensive surveillance is recommended [4] . In previous studies [22] we could demonstrate that alterations in maternal cardiac output as well as the fluid intake in the lungs can be continuously monitored by means of noninvasive thoracic impedance cardiography.
The interest in developing noninvasive methods for fetal blood flow measurements has gradually increased. Meanwhile pulsed doppler ultrasonography offers the possibility of estimating data on fetal blood flow characteristics [3, 11, 14] . The subject of the following investigation was to combine both thoracic impedance cardiography and pulsed doppler ultrasonography for the simultaneous noninvasive estimation of maternal and fetal hemodynamics during hypervolemic hemodilution in preeclampsia. In humans the simultaneous monitoring of both hemodynamic systems has not been focused as yet.
Material and methods
This preliminary report summarizes the investigations in five preeclamptic women in the last trimester of pregnancy. All patients were admitted to hospital care with raised mean arterial blood pressure (MAP > 103.3 mm Hg) and hemoconcentration (hematocrit > 38%). The ultrasonographic estimation of the fetus in all cases showed no anatomical malformations. Patients' characteristics are summarized in table I.
The antenatal fetal weight was estimated according to the chest and head circumferences. All patients were without any antihypertensive drug treatment or diuretics. The basic treatment consisted of bed rest prior to hypervolemic hemodilution. Informed consent was obtained from all patients, who were included in this study.
Clinical procedure
Hypervolemic hemodilution was performed with 500ml low molecular dextran* intravenously over a period of exactly 60 minutes. Twenty ml of hapten** was preinjected to avoid anaphylactic reactions.
Twentyfour hours after dextran application the same patients received 500 ml physiologic saline solution using the same conditions compared to hypervolemic hemodilution with dextran. This placebo-controlled procedure in intraindividual comparison was performed to distinguish between specific dextran effects and nonspecific effects of isovolemic hemodilution with NaCl on the maternal and fetal circulatory system. During dextran and NaCl supply, the following hemodynamic parameters were monitored in 15-minutes intervals: maternal: heart rate, blood pressure, stroke volume, cardiac output (calculated as cardiac index); fetal:
heart rate, flow velocity and flow volume in the descending aorta and umbilical vein.
In the following 60-minutes period after the end of infusion these measurements were repeated at 15 minutes (p 15), 30 minutes (p 30) and 60 minutes (p 60). In each patient a total of eight measurements were carried out for both dilution regimen. All hemodilutions were performed at the same daytime (afternoon) to avoid possible undesired side effects due to maternal and fetal circadian rhythm.
Technical equipment
Maternal hemodynamics: We used the IFM Impedance Cardiograph, model 400*. ECG, phonocardiogram, the impedance signal delta Z and its first derivate dZ/dt were recorded via a multichannel plotter. Beat-to-beat calculations of isolated stroke volume and the cardiac output were estimated with a büilt-in ZCGComputer*. This computer was triggered by two potentiometers, which indicate the respective distances of the internal electrode bands and the specific hematocrit-dependent resistance of blood [15] . Heart rate was derived from the ECG-recordings. (11) 63.0 (16) 87 (11) 67.0 (19) 87 (12) 67.9 (20) 86 (8) 72.9 (16) 85 (2) 66.9 (16) 84 (11) 70.7 (16) 82 (9) 72.2 (14) 87 (11) 68. 
Statistics
Statistical analysis included the Student's t-test for paired observations. The correlation coefficients were calculated using the overall mean value per measurement.
Results

Maternal hemodynamics
Hypervolemic hemodilution with 500ml dextran induced an increase in cardiac index which was mainly due to elevated stroke volume. Beat-to-beat registration of isolated stroke volume revealed an increase from 69.9 ml prior to infusion to 83.6 ml 45 minutes after the beginning of plasma volume expansion. In the following period up to 60 minutes post infusionem, both the cardiac index and the stroke volume slightly decreased but did not reach the respective values at rest prior to hypervolemic hemodilution. No remarkable changes in maternal heart rate and mean arterial blood pressure were found during the total period of investigation. In the course of normovolemic hemodilution with 0.9% NaCl the intraindividual comparison for all parameters showed no statistically significant differences throughout the 120 minutes period. Table II summarizes the mean values (x) and standard deviations (SD) for heart rate, stroke volume and cardiac index for both dextran and NaCl procedures.
Fetal hemodynamics
As an exemplary illustration figures 1 and 2 show the original recordings of doppler shifts in case 3 (Pat. F. R.) at three different times during hypervolemic hemodilution: prior to infusion, 30 minutes after the beginning and finally 60 minutes after the end of dextran application.
In this case fetal blood flow parameters could be investigated in the descending aorta (figure 2) as well as in the umbilical vein ( figure 1 ).
The alterations in fetal hemodynamics in this patients are representive for our general experience in all cases. During hypervolemic hemodilution we found a significant increase in blood velocity which was also evident within the follow-up period of 60 minutes after dextran supply. Aortic flow volume rose from 216ml/min, kg to 268 ml/min, kg at time p 15 and remained nearly unchanged till the end of observation.
During NaCl infusion no significant changes in fetal circulation could be exhibited. The results are summed up in Table III . Figure 3 illustrates the percent changes in maternal cardiac index and fetal aortic flow volume/kg body weight in comparison between dextran and NaCl supply. In the course of maternal plasma volume expansion both circulatory systems react with an increase in cardiac output. In fetal cardiovascular system this effect is maintained till 60 minutes after the end of dextran infusion (p 60), whereas maternal cardiac output constantly decreases within p 15 and p 60.
Fetal blood flow velocity in the descending aorta and maternal cardiac index strongly correlate (figure 4) on the analysis of the mean values of both parameters during hypervolemic hemodilution. prior to infusion 127 (7) 22.8(3.9)
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Discussion
In animal experiments SCHR CK et al. [17] in- A > u · · t. r between dextran 40 and albumin, tary and appear to be a promising approach for noninvasive estimation of maternal and fetal During hypervolemic hemodilution we estimatcirculation. Thoracic impedance cardiography ed an increase in fetal blood flow velocity and is easy to perform and particularly suited for flow volume in the umbilical vein and in the the determination of changes in cardiac per-descending aorta. From these results it can be formance during a longtime period. This tech-concluded that an elevated maternofetal fluid nique enables the interindividual study of circu-exchange could occur, although low molecular latory effects of different therapeutic proce-dextran does not pass the placenta [13] . dures such as fluid therapy. In previous studies T t ~ ., , , the different pressure gradients between fetal vessel [3] . This study protocol was de-placental blood flow and the umbilical vessels signed as an intraindividual longitudinal study; PQ-In cases of preeclampsia, BENEDETTI and the individual vessel diameter remained con-CARLSON [2] described maternal colloidosmotic stant within the whole period of investigation pressure to be significantly lower than in norand the angle between doppler stream and ves-motensive pregnancies. The normal range of sei wall was in the range between 43° and 63° maternofetal colloidosmotic pressure gradient (mean: 53.1° + 4.5°). * s a^o ut 52 mm EbO [17] and rises up to 92 mm~ HbO in cases with preeclampsia and intrauterIn pre-eclampsia, maternal hemodynamics are ine growth retardation [17] . In pregnant ewes, characterized by a lack of plasma volume ex-stepwise hypervolemic hemodilution with albupansion and a raised total peripheral resistance min leads to a slight fetal hemodilution, which [8] , Elevated hematocrit is a good indicator of can be identified by a further decrease in fetal deficient plasma expansion [10] . In contrast to colloidosmotic pressure [17] . The elevated hy-ASSALI et al. [1] we support the opinion of drostatic intervillous pressure, induced by plas-GROENENDUK et al. [8] that plasma expansion ma volume expansion might be responsible for in pre-eclampsia is of potential benefits to the net flow of water into the fetal circulation, maintain a normal cardiac index such as the Nevertheless improved blood flow properties in physiological conditions in normal pregnancy, the course of plasma expander therapy may Hemodilution with oncotic active drugs also also play an additive role in the fetoplacental improves blood flow behavior in microcircula-water transfer. Further studies are warranted tion [9] .
to support these preliminary experiences.
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Summary
In pre-eclampsia hemodynamic alterations are characterized by a lack of plasma volume expansion and a raised peripheral vascular resistance. For the compensation of plasma volume deficit and to restitute blood fluidity the therapeutic use of plasma volume expanders (f. e. low molecular dextran) is recommended. Several groups (GooDLiN et al. [6] , CLOEREN et al. [4] , HEILMANN et al. [9] , SEGHAL et al. [20] , SCHRÖCK [18] ) have demonstrated benefitial effects on fetal status and development in the course of hypervolemic hemodilution in preeclampsia. This therapeutic procedure presumes the continuous surveillance of maternal hemodynamics to early recognize heart insufficiency or fluid overload in the lungs. We use the noninvasive thoracic impedance cardiography for continuous monitoring of maternal heart perform-\ ance. The effect of hypervolemic hemodilution on fetal circulation has not been quantitatively investigated yet. Meanwhile pulsed doppler ultrasonography offers the possibility of estimating quantitative changes on fetal blood flow. We used both noninvasive techniques -thoracic impedance cardiography and pulsed doppler imaging system -for the simultaneous evaluation of maternal and fetal hemodynamic parameters during hypervolemic hemodilution. This preliminary report summarizes the investigations in 5 patients with pre-eclampsia (mean arterial blood pressure > 103.3 mm Hg, hemoconcentration with elevated hematocrit levels > 38%). The patients received an infusion of 500 ml dextran 40 over a period of exactly 60 minutes. The simultaneous measurements of maternal and fetal cardiovascular parameters were performed in 15-minutes intervals during dextran application and 15 minutes (p 15), 30 minutes (p 30) and 60 minutes (p 60) after the end of infusion. Twentyfour hours after dextran application the same patients received 500ml physiological saline infusion under the identical conditions to distinguish between dextran specific and nonspecific effects of maternal hemodilution in iiitraindividual comparison. Results: Hypervolemic hemodilution with dextran 40 induced a significant increase in maternal cardiac index, the maximum values of cardiac index were registrated 45 minutes after the starting of infusion. In the following 60 minutes after the end of dextran supply cardiac index slightly decreased. During the infusion of 500 ml 0.9% NaCl solution maternal cardiac index at all times remained nearly unchanged. Maternal heart rate and mean arterial blood pressure showed no remarkable alterations for both hemodilution regimen. Fetal aortic blood flow velocity significantly increased during and after dextran application. Fetal aortic blood flow volume also showed a significant increase (+ 20%) and remained elevated up to 60 minutes after the end of infusion. Original recordings of fetal doppler shifts (aorta descendens, vena umbilicalis) are giving evidence of the investigated data. Fetal blood flow velocity in the descending aorta and' maternal cardiac index strongly correlated (r = 0.908). In contrast during and after NaCl infusion no quantitative changes in fetal flow velocity and flow volume could be exhibited. Discussion: These preliminary observations indicate that hypervolemic hemodilution in preeclampsia correlate with a rise in fetal blood flow velocity and flow volume. This fact might be due to elevated uteroplacental perfusion via raised maternal cardiac output. In intraindividual comparison nonnovolemic hemodilution do not demonstrate similar effects. In accordance to animal studies (SCHRÖCK, [17] ) plasma volume expansion leads to elevated hydrostatic intervillous pressure, which might be responsible for the net flow of water into fetal circulation. Further studies are warranted to support these first experiences. Despite more than a century of ever-increasing scientific interest and research, anorexia nervosa -the pathological pursuit of thinness -still presents a challenge to clinicians throughout the world. It has become practically impossible to keep in touch with the constant proliferation of scientific literature on this subject. Moreover, the clinician (the general practitioner, the psychiatrist or the psychologist) needs, first and foremost, practical guidelines for his everyday therapeutic work with these patients.
Keywords
Therefore, two experienced clinicians, who are daily involved in research and treatment of large numbers of anorexia nervosa patients, decided to write the first book dealing extensively with the many practical issues one is faced with when investigating and treating anorectic patients of all ages and in all stages of their illness. No single treatment modality, psychotherapeutic, pharmacologic or nutritional, has provided the final solution for the management of this intriguing syndrome. Hence, the therapeutic approach described in this book is characterized as an eclectic, broad spectrum or multimodal treatment in which strategies and interventions from different therapeutic models have been integrated. 
